Gradual brain replacement in a quest to preserve our marbles as we age, an idea pionered by Jean Hebert, has fascinated me for a while. And now Jean finds himself at DARPA-H with resources to advance it. Read this story by Antonio Regalado at the MIT Technology Review, https://lnkd.in/d6e74agf.
About us
quadraScope (www.quadrascope.com) invests in early-stage healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices enabling biological age reversal, disease treatment and prevention .
- Website
-
http://www.quadrascope.com
External link for quadraScope
- Industry
- Investment Management
- Company size
- 2-10 employees
- Headquarters
- Boston
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Launching new ventures, Clinical rejuvenation, Preventive medicine, Regenerative medicine, Artificial intelligence for biology, and Longevity biotech
Locations
-
Primary
Get directions
Boston, US
Employees at quadraScope
Updates
-
quadraScope reposted this
Super exciting development for Boston biotech. Lilly is also actively watching the trends in longevity biotech being advanced by brilliant scientists at the numerous Boston area universities. Go East! Julie Gilmore Vanessa Barth Vadim Gladyshev Leon Peshkin Sergiy Velychko Jonathan Kittel Alex Zhavoronkov Steven Wardell William Greene Michael AnthonyJosé Navarro Betancourt, MD, PhD Michael LevinCarmela AbrahamMenachem AbrahamAubrey de GreyDiane SeimetzNico HellingNikola T. MarkovNir BarzilaiDaniel FylstraRobert S. Cargill, PhDMiri Polachek
Bold science happens here. Today marks the official opening of the Lilly Seaport Innovation Center (LSC), our new state-of-the-art research and development facility focused on finding solutions that can help people around the world live healthier. Tackling some of the most complex health challenges requires the right team of experts, the right technology and right environment to support smart, bold risks. LSC is focused on cutting edge science and genetic medicines to deliver for people who need it most: https://e.lilly/4dmDuL8 #WeAreLilly
-
-
Interview of our Scientific Director José Navarro Betancourt, MD, PhD by one of the luminaries of our industry. The interview covers the amazing opportunities in longevity investing, science, advancements and reality of longevity care today (1hr 45 min) https://lnkd.in/ewmT2s95
Investing & Lifestyle Principles with Longevity VC
https://www.youtube.com/
-
I look forward to speaking on the topic of Live Long Enough To Live Forever on Thur. July 11 at 5:30pm at the Intercontinental Boston. Sign up at: https://lu.ma/6dpkruxk and use the promo code DH25 for a 25% discount. Steven Wardell
Boston Health Innovation Night · Luma
lu.ma
-
We're thrilled to announce that Matter Bio, our portfolio company, has closed its $7M Seed round. Congratulations!
Happy and humbled to share we have closed our seed round. Thank you to all our investors, collaborators and team member for making this a reality. Extra special thanks to my co-founders Sam Sharifi, PhD , Jan Vijg, George Church,Alexander Maslov and Claudia Gravekamp. Onward!
Matter Bio lands seed funding for longevity therapeutics that preserve genomic integrity
https://longevity.technology
-
Congratulations to our portfolio company, Turn Biotechnologies, for its partnership with HanAll Biopharma to develop treatments for age-related ocular and auditory diseases.
Turn Bio inks $300m epigenetic reprogramming deal with HanAll Biopharma
Phil Newman on LinkedIn
-
quadraScope reposted this
Thanks to Chris Patil and Kristen Fortney of BioAge Labs for hosting a fantastic Boston Longevity Biotech Mixer, featuring talks by Spring Behrouz, Mahdi Moqri, and Alex Plesa. Thanks also to Felicis for sponsoring. If you have yet to attend one of these events, we hope to see you at the next one. #longevity
-
Many thanks to Longevity Global Boston for dedicating this month's event to #biomarkers of #aging. Jesse Poganik and Mahdi Moqri highlighted the work of the Biomarkers of Aging Consortium and shared their latest academic research on #epigenetics of aging. Fiona Miller discussed quadraScope's strategic interest in technologies to monitor aging and the effectiveness of longevity #healthcare.
-
-
quadraScope reposted this
Thank you to quadraScope for sponsoring our Longevity Global BOS event on Biomarkers of Aging next Tuesday in Cambridge! https://lu.ma/1lctg3mf
Longevity Global BOS: Biomarkers of Aging Event · Luma
lu.ma
-
Super-interesting news on the success of organ xeno-transplantation (from Boston, my fair city!). Kudos to George Church and eGenesis, Inc.. If xeno-transplantation continues to prove successful, this should curb the need for organ cryopreservation. Ability to replace failing organs is obviously a big win for longevity healthcare. Replacing the aging brain tissue is our next challenge. https://lnkd.in/eaxD9XqS
First-ever transplant of pig kidney to patient a success — Harvard Gazette
https://news.harvard.edu/gazette